Not sure how useful a review of Alzheimer's drugs is when you combine licensed drugs with failed drugs and look at the average.
Over 53 million family caregivers worldwide provide daily, often unseen care for loved ones. Eleanor Gaccetta highlights the true global scale and emotional weight of caregiving, revealing a reality that affects families everywhere.
Read more: https://www.onecaregiversjourney.com/how-many-family-caregivers-worldwide/
#Caregiving #FamilyCaregivers #CaregiverSupport #Dementia #Alzheimers #CaregiverLife
Madeleine Finlay sits down with co-host and science editor Ian Sample to discuss three eye-catching stories from the week, including a review into the effectiveness of a new class of Alzheimer’s drug that was once hailed as a game-changer in slowing the progress of the disease. Also on the agenda is the news that the world could be heading for a ‘super El Niño’ this summer and a study exploring whether conversations about dull topics really are as boring as we expect them to be
Baristas get more training than dementia carers, research shows
This brief note highlights material that resonates with mental health professionals by illustrating how sustained cognitive enrichment can influence brain aging and symptom onset. The emphasis on lifelong engagement in reading, writing, and learning aligns with approaches that support cognitive reserve and resilience, which are of interest to therapists, social workers, and other clinicians working with aging clients.
Article Title: Doing this throughout life may cut Alzheimer’s risk by 38%
Link to Science Daily Mind-Brain News: https://www dot sciencedaily dot com/releases/2026/04/260414075648 dot htm
#alzheimers #cognitivescience #mentalhealth #agingwell #neuroscience
Copy and paste broken link above into your browser and replace "dot" with "." for link to work.
We have to do it this way to avoid display of copyrighted images.
Are standard Alzheimer's meds plateauing? Explore Integrative Alzheimer's Treatment in China. Top hospitals are combining neurology & multi-target TCM to safely combat cognitive decline.
As a medical concierge provider, MedBridgeNZ doesn't treat—we facilitate. We expertly manage your Medical Tourism China journey, connecting you to top specialists.
Read the evidence: https://zurl.co/OtbUb
#Neurology #Alzheimers #MedicalConcierge #MedBridgeNZ #MedicalTourismChina #ChinaMedicalTourism
Home > Blog > Advanced Therapies & TechnologyKey Takeaways • Limitations of Single-Target Drugs: Mainstream single-target Alzheimer's medications often face a 6 to 12-month "efficacy plateau" and present significant side effect profiles, including gastrointestinal issues and Amyloid-Related Imaging Abnormalities (ARIA). • Integrative Clinical Evidence: A meta-analysis of 23 randomized controlled trials involving 2,035 patients demonstrated that integrating multi-target plant-based compounds with
Research Links Early Smell Loss to Alzheimer's Disease
📰 Original title: Study Reveals Loss Of Smell May Be An Early Warning Sign Of Alzheimer's
🤖 IA: It's clickbait ⚠️
👥 Usuarios: It's clickbait ⚠️
View full AI summary: https://killbait.com/en/research-links-early-smell-loss-to-alzheimers-disease/?redirpost=697c2db0-e1ba-497c-ae52-d5c8081dfa8c
Alexander J. Stein
Adam Jacobs 🇺🇦
Rix Luz
The Japan Times
Science | The Guardian
Metro – Metro.co.uk: News, Sport, Showbiz, Celebrities from Metro
Psychotherapy Commission ACPE
MedBridgeNZ
KillBait News